Figure 10 is titled “Standardized mean change from baseline to end of treatment in depression symptoms (BDI) for exposure therapy compared with inactive comparator.” The figure displays a forest plot reporting standardized mean difference in depression (as measured by the Beck Depression Inventory), exposure therapy versus inactive comparators. This figure is described further in the “Prevention or Reduction of Comorbid Conditions” section as follows: “Results of our meta-analysis indicated a greater reduction in BDI depressive symptom scores for subjects treated with exposure than for those in wait-list or usual-care inactive comparator groups (SMD, −0.76; 95% CI, −0.91 to −0.60; I2=19.4%, 10 trials [11 comparisons], N=7,152, Figure 10; high SOE.”

Figure 10Standardized mean change from baseline to end of treatment in depression symptoms (BDI) for exposure therapy compared with inactive comparator

BDI: Beck Depression Inventory; CI = confidence interval; PE = prolonged exposure; SMD = standardized mean difference; VRE = virtual reality exposure.

From: Results

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 207.
Forman-Hoffman V, Middleton JC, Feltner C, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.